In hemodialysis, adiponectin, and pro-brain natriuretic peptide levels may be subjected to variations in body mass index

Hemodialysis International

Volumn 15, Issue 4, 2011, Pages 477-484

  Trimarchi, Hernan ^a   Muryan, Alexis ^a   Dicugno, Mariana ^a   Forrester, Mariano ^a   Lombi, Fernando ^a   Young, Pablo ^a   Pomeranz, Vanesa ^a   Iriarte, Romina ^a   Barucca, Nanci ^a   Campolo Girard, Vicente ^a   Alonso, Mirta ^a   Lindholm, Bengt ^b  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adiponectin; Body mass index; Cardiovascular disease; Hemodialysis; Insulin; Malnutrition inflammatory score; Pro BNP; Restrictive cardiomyopathy

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INSULIN; TROPONIN T;

ADULT; ARTICLE; BODY FAT; BODY MASS; CORRELATION ANALYSIS; FEMALE; HEART HYPERTROPHY; HEART VENTRICLE REMODELING; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INSULIN RESISTANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; ULTRAFILTRATION;

ADIPONECTIN; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOMEGALY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 80054891935     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00562.x     Document Type: Article

References (42)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HFA novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995; 270:26746-26749.
2. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004; 89:2563-2568.
3. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipocyte-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257:79-83.
4. Psichon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291:1730-1737.
5. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005; 54:534-539.
6. Frystyk J, Tarnow L, Krarup Hansen T, Parving HH, Flyvberg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia. 2005; 48:1911-1918.
7. Hadjadj S, Aubert R, Fumeron F, et al. Increased plasma adiponectin concentrations are associated with microangiopathy in tyoe 1 diabetic subjects. Diabetologia. 2005; 48:1088-1092.
8. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112:1756-1762.
9. Drechsler C, Krane V, Winkler K, Dekker FW, Eanner Cfor the German Diabetes and Dialysis Study InvestigatorsKidney Int. 2009; 76:567-575.
10. Becker B, Kronenberg Ffor the MSGet al. renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The Mild and Moderate Kidney Disease Study. J Am Soc Nephrol. 2005; 16:1091-1098.
11. Zocalli C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13:134-141.
12. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005; 90:4542-4548.
13. Menon V, Lijun L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. Am Soc Nephrol. 2006; 17:2599-2606.
14. Ades PA, Savage PD. The obesity paradox: Perception vs knowledge. Mayo Clin Proc. 2010; 85:112-115.
15. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004; 80:324-332.
16. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63:793-808.
17. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH.A Malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001; 38:1251-1263.
18. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004; 19:1507-1519.
19. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004; 68:975-981.
20. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004; 109:594-600.
21. Sarzani R, Dessi-Fulgheri P, Paci VM. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest. 1996; 19:581-585.
22. Sengenes C, Berlan M, De Glisezinski I. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 2000; 14:1345-1351.
23. Tanaka T, Tsutamoto T, Sakai H. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail. 2008; 10:360-366.
24. Poulsen SH. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infraction. Dan Med Bull. 2001; 48:199-210.
25. Duhaney SF, Duhanney TA, Sato K, et al. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure. Endocrinology. 2010; 151:322-331.
26. Pääko T, Ukkola O, Ikäheimo M, Kesäniemi YA. Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med. 2010; 42:131-137.
27. Trimarchi H, Muryan A, Campolo-Girard V, et al. Elevated Pro-Brain natriuretic peptide, troponin T ans Malnutrition Inflammatory Score in chronic hemodialysis patients with overt cardiovascular disease. Nephron Clin Pract. 2011; 117:198-205.
28. Mallamaci F, Zocalli C, Parlongo S, et al. Troponin T is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2002; 40:68-75.
29. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sex-related differences in the Framingham Heart Study. Circulation. 2003; 107:448-454.
30. Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004; 10:1384-1389.
31. Mishra R, Cool B, Laderoute K, Foretz M, Viollet B, Simonson M.AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem. 2008; 283:10461-10469.
32. Ma K, Cabrero A, Saha PK, et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem. 2002; 277:34658-34661.
33. Von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipemia, and heart failure in patients with coronary heart disease. Clin Chem. 2006; 52:853-859.
34. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001; 86:3815-3819.
35. Ouchi N, Kihara S, Funahashi T. Reciprocal association of C-Reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003; 107:671-674.
36. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein activation. Eur J Endocrinol. 2003; 148:657-662.
37. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994; 121:860-862.
38. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001; 98:2005-2010.
39. Qi Y, Takahashi N, Hileman SM, et al. adiponectin acts in the brain to decrease body weight. Nat Med. 2004; 10:524-529.
40. George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart. 2006; 92:1420-1424.
41. Berg AH, Combs TP, Du X. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7:947-953.
42. Yamauchi T, Kamon J, Waki H. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesisty. Nat Med. 2001; 7:941-946.